NO782302L - CONTAINER FOR TWO-COMPONENT MIXTURES - Google Patents
CONTAINER FOR TWO-COMPONENT MIXTURESInfo
- Publication number
- NO782302L NO782302L NO782302A NO782302A NO782302L NO 782302 L NO782302 L NO 782302L NO 782302 A NO782302 A NO 782302A NO 782302 A NO782302 A NO 782302A NO 782302 L NO782302 L NO 782302L
- Authority
- NO
- Norway
- Prior art keywords
- container
- component
- distribution channel
- flanges
- capsule
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 23
- 239000002775 capsule Substances 0.000 claims description 25
- 238000005192 partition Methods 0.000 claims description 17
- 238000009826 distribution Methods 0.000 claims description 13
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 4
- 239000013543 active substance Substances 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920006332 epoxy adhesive Polymers 0.000 description 1
- 238000009093 first-line therapy Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2093—Containers having several compartments for products to be mixed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/202—Separating means
- A61J1/2027—Separating means having frangible parts
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Package Specialized In Special Use (AREA)
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
Description
Foreliggende oppfinnelse vedrorer en beholder for blandinger av to komponenter som skal holdes hver for seg. under lagring og bare blandes kort tid for bruk eller anvendelse. The present invention relates to a container for mixtures of two components which are to be kept separately. during storage and only mixed briefly before use or application.
Formålet med oppfinnelsen er å tilveiebringe en beholder i form av en kapsel som i atskilte avdelinger kan inneholde to komponenter, som kan blandes med hverandre og por-sjoneres ut på enkel måte, og denne kapselen kan fremstilles<p>g fylles ved hjelp av kjente fremstillingsteknikker. Et videre formål er å tilveiebringe en slik kapsel som er nyttig som en én-dosis-beholder for farmasoytiske preparater hvor kapselen inneholder to komponenter av preparatet. The purpose of the invention is to provide a container in the form of a capsule which can contain two components in separate compartments, which can be mixed with each other and portioned out in a simple way, and this capsule can be prepared and filled using known manufacturing techniques. A further object is to provide such a capsule which is useful as a single-dose container for pharmaceutical preparations where the capsule contains two components of the preparation.
Farmasøytiske preparater som foreligger i form av to komponenter er hovedsakelig blandinger av antibiotika så-som penicillinblandinger som spesielt anvendes i barnemedi-sinen. Slike blandinger fordeles vanligvis til apotekene som tort granulat i glassflasker. Foran bruk fremstilles, blandingen ved å tilsette en mengde destillert vann og blande denne med granulatet. Ulempene ved denne bruksmåte er. at fremstillingen av blandingen er tidkrevende og også forår-saker risiko for.stov og folgelig fare for allergi hos per-sonalet i apoteket. Dekomponering av den aktive komponent finner videre sted i lopet av relativt kort tid etter fremstil-j. Pharmaceutical preparations that exist in the form of two components are mainly mixtures of antibiotics such as penicillin mixtures which are particularly used in children's medicine. Such mixtures are usually distributed to pharmacies as dry granules in glass bottles. Before use, the mixture is prepared by adding a quantity of distilled water and mixing this with the granulate. The disadvantages of this method of use are. that the preparation of the mixture is time-consuming and also causes a risk of dust and, consequently, a risk of allergy among the staff in the pharmacy. Decomposition of the active component further takes place in the course of a relatively short time after preparation.
ling av blandingen, og dekomponeringsproduktene som dannes kan forårsake allergiske reaksjoner hos pasienten. Videre må enkeltdosene måles ut for tilforsel og dette betyr risiko for ukorrekt måling og spill. Som ytterligere ulemper, spesielt ved bruk i sykehus, skal nevnes at separate doser .etter ut-måling ikke er merket og har dermed en risiko for sammenbland- .ing og at store mengder blanding idag kastes på grunn av dekomponering av innholdet. ling of the mixture, and the decomposition products that are formed can cause allergic reactions in the patient. Furthermore, the individual doses must be measured out for administration and this means a risk of incorrect measurement and spillage. As further disadvantages, especially when used in hospitals, it should be mentioned that separate doses after measurement are not marked and thus have a risk of mixing up, and that large quantities of the mixture are today thrown away due to decomposition of the contents.
Som én-dosepakker har anvendt poser som inneholder én dosis granulat utmålt, og denne dosis skal blandes med vann for inntak. Doseringsposene har den ulempe at vannet må måles ut for hver dosis og at blandingen må finne sted i et separat kar og at der er risiko for spill og ikke korrekt fremgangsmåte ved fremstillingen. En risiko for forbytting på grunn av mangel på merking av det endelige preparat er f også tilstede når de nevnte doseringsposer anvendes. Dos.etf^ ingsposer har således hovedsakelig vært brukt i forste tera-pi. As single-dose packages, bags containing one dose of measured granules have been used, and this dose must be mixed with water for ingestion. The dosing bags have the disadvantage that the water must be measured out for each dose and that the mixture must take place in a separate vessel and that there is a risk of spillage and incorrect manufacturing procedures. A risk of substitution due to a lack of labeling of the final preparation is also present when the aforementioned dosage bags are used. Dosing bags have thus mainly been used in primary therapy.
Ikke-farmasbytiske blandinger i form av to komponenter som må holdes atskilt under lagring er blitt mer og. mer vanlig. Således har lim i to-komponentsform, spesielt epoksilimer fått stor bruk. Non-pharmaceutical mixtures in the form of two components that must be kept separate during storage have become more and. more common. Thus, adhesives in two-component form, especially epoxy adhesives, have been widely used.
Emaljer som består av en basiskomponent og en herd-ner er også vanlig. Et annet bruksområde for to-komponents-blandinger er f.eks. midler for munnbehandling.. Videre har man i mange tilfeller en torr 'komponent som man onsker å opp-lbse eller dispergere i en væskekomponent like for bruk. Enamels consisting of a base component and a hardener are also common. Another area of use for two-component mixtures is e.g. agents for oral treatment. Furthermore, in many cases one has a dry component which one wishes to dissolve or disperse in a liquid component just before use.
Fransk patent 2.291.115 viser en container med atskilte rom for en basiskomponent og en annen komponent hvor den annen komponent plaseres i en kapsel på toppsiden av beholderen og hvor blandingen finner sted ved å perforere skilleveggen mellom kapselen og beholder for basiskomponenten ved å presse ned et brytepunkt arransjert i den ytre vegg av kapselen. Ulempene ved en slik beholder er at den har en kompli-sert form ved separert plaserte åpninger for tilfbrsel av den annen komponent og for å fordele blandingen. Fremstilling av denne beholder vil * være så kostbar' at den ikke kan anvendes French patent 2,291,115 shows a container with separate compartments for a base component and another component where the second component is placed in a capsule on the top side of the container and where mixing takes place by perforating the partition between the capsule and container for the base component by pressing down a breaking point arranged in the outer wall of the capsule. The disadvantages of such a container are that it has a complicated shape with separately placed openings for supplying the second component and for distributing the mixture. Manufacturing this container will *be so expensive' that it cannot be used
som en én-dososbeholder for farmasbytiske preparater. as a single-dose container for pharmaceutical preparations.
Ulempene ved de tidligere fremgangsmåter unngås på en forbausende måte ved den ±>religgende oppfinnelse som til-veiebringer en beholder for to-komponentblandinger som består av to lukkede rom som hvert skal inneholde én komponent av en blanding, og disse rom er skilt fra hverandre ved en skillevegg som kan brytes ved å presse på en kant som er orientert innover i den ytre vegg i beholderen for å blande komponentene, og som erkarakterisert vedat beholderen består av to kapselhalvdeler som stort sett er formet på tilsvarende måte som The disadvantages of the previous methods are surprisingly avoided by the present invention, which provides a container for two-component mixtures which consists of two closed compartments which must each contain one component of a mixture, and these compartments are separated from each other by a partition which can be broken by pressing on an edge which is oriented inwardly in the outer wall of the container for mixing the components, and which is characterized in that the container consists of two capsule halves which are generally shaped similarly to
kupler utstyrt med flenser hvorimellom skilleveggen holdes, hvor minst én av flensene er forlenget for å danne en spiss og sammen med skilleveggen danne en fordelingskanal som kan åpnes ved å fjerne spissen for beholderen tommes ved å presse den. domes equipped with flanges between which the partition is held, where at least one of the flanges is extended to form a tip and together with the partition to form a distribution channel which can be opened by removing the tip for the container to be emptied by pressing it.
Ifolge en foretrukket utforelse av oppfinnelsen, er beholderen en én-dosisbeholder for et farmasoytisk preparat som i stbrrelse og materialer passer fir et slikt formålt '.: Ifolge en annen foretrukket utforelse er den frem-stikkende del av flensen utstyrt med en tversgående bruddlinje, dvs. en linje hvor styrken i materialet er redusert slik at den lett vil kunne brekkes langs den nevnte linje, slik at fordelingskanalen kan åpnes uten at der anvendes verktby. According to a preferred embodiment of the invention, the container is a single-dose container for a pharmaceutical preparation which in terms of structure and materials is suitable for such a purpose. According to another preferred embodiment, the projecting part of the flange is equipped with a transverse break line, i.e. .a line where the strength of the material has been reduced so that it can easily be broken along the said line, so that the distribution channel can be opened without the use of werktby.
Ifolge en spesielt foretrukket utforelse av oppfinnelsen, er fordelingskanalen plasert i den lavere kapselhalvdel som skal inneholde en torr komponent og den innoverorienterte kant er arransjert i den ovre kapselhalvdel som skal inneholde en flytende komponent. Ved dette arransjement vil man få maksimal' blanding og fordeling av blandingen. Fortrinnsvis er den innoverorienterte kant arransjert i nærheten av fordelingskanalen for beholderen. According to a particularly preferred embodiment of the invention, the distribution channel is placed in the lower capsule half which is to contain a dry component and the inwardly oriented edge is arranged in the upper capsule half which is to contain a liquid component. With this arrangement, maximum mixing and distribution of the mixture will be obtained. Preferably, the inwardly oriented edge is arranged near the distribution channel of the container.
Et farmasoytisk preparat i doseringsenhetsform som består av en torr komponent og en flytende komponent, hvor én eller begge komponenter utgjores.av en terapeutisk effektiv dose av en aktiv substans og hvor én eller begge komponentene omfatter et farmasoytisk akseptabelt bærestoff eller for-tynningsmiddel som erkarakterisert vedat de to komponentene holdes i atskilte rom i en beholder som omfatter to lukkede rom dannet av to kapselhalvdeler som stort sett er formet på tilsvarende måte som to kupler utstyrt med flenser, hvorimellom en skillevegg som skiller de to rommene holdes, hvor skilleveggen kan brytes ved å manipulere beholderen fra utsiden og hvor minst én flens strekkes frem til en spiss som sammen med skilleveggen danner en fordelingskanal som kan åpnes ved å fjerne spissen for beholderen tommes utgjor en annen side ved oppfinnelsen. A pharmaceutical preparation in dosage unit form consisting of a dry component and a liquid component, where one or both components are made up of a therapeutically effective dose of an active substance and where one or both components comprise a pharmaceutically acceptable carrier or diluent which is characterized by the two components are kept in separate compartments in a container comprising two closed compartments formed by two capsule halves which are generally shaped similarly to two domes fitted with flanges, between which a partition separating the two compartments is kept, the partition being breakable by manipulating the container from the outside and where at least one flange is extended to a tip which, together with the partition, forms a distribution channel which can be opened by removing the tip for the container to be empty constitutes another aspect of the invention.
Oppfinnelsen er nærmere beskrevet under henvisning The invention is described in more detail under reference
til de vedheftede tegninger.to the attached drawings.
Fig. 1 viser en beholder ifolge oppfinnelsen sett ovenfra. Fig. 2 viser et snitt langs linjen 2-2 i fig. 1. Fig..3 viser beholderen ifolge oppfinnelsen sett fra Fig. 1 shows a container according to the invention seen from above. Fig. 2 shows a section along the line 2-2 in fig. 1. Fig..3 shows the container according to the invention seen from the side
siden med en etikett, ogthe page with a label, and
fig. 4 viser en perspektivskisse av en beholder ifolge oppfinnelsen. fig. 4 shows a perspective sketch of a container according to the invention.
I tegningene benevner 1 den ovre kuppelformede kapselhalvdel og 2 den lavere kuppelformede kapselhalvdel. Kapselhalvdelene er utstyrt med flenser 3 og 4 hvorimellom den membranformede skillevegg 5 er plasert. Skilleveggen 5 danner sammen med kapselhalvdelene 1 og 2 lukkede, atskilte rom som inneholder tilmålte mengder av henholdsvis to komponenter 6 og 7. I et farmasoytisk preparat kan den torre komponent 6 være granulat og komponenten 7 kan være en væske. Den. ovre kapselhalvdel 1 er utstyrt med en kant 8 som vender innover som ved å bli presset ned vil bryte skilleveggen. Flensene 3 og 4 og skilleveggen 5 er strukket frem til en spiss 9 hvor en fordelingskanal 10 er plasert, som kan åpnes ved å bryte av spissen 9 langs bruddlinjen 11. En merkelapp 12 kan plaseres som en sadel over spissen 9 og tjener derved i tillegg til å merke, som beskyttelse for kontakt med spissen under trans-port av beholderen. - Beholderen vist i tegningene anvendes på folgende måte: In the drawings, 1 designates the upper dome-shaped capsule half and 2 the lower dome-shaped capsule half. The capsule halves are equipped with flanges 3 and 4 between which the membrane-shaped partition wall 5 is placed. The partition wall 5 together with the capsule halves 1 and 2 form closed, separate spaces which contain measured quantities of two components 6 and 7 respectively. In a pharmaceutical preparation, the dry component 6 can be granules and the component 7 can be a liquid. It. upper capsule half 1 is equipped with an edge 8 facing inwards which, by being pressed down, will break the partition wall. The flanges 3 and 4 and the partition wall 5 are stretched to a tip 9 where a distribution channel 10 is placed, which can be opened by breaking off the tip 9 along the fracture line 11. A label 12 can be placed as a saddle over the tip 9 and thereby serves in addition to mark, as protection for contact with the tip during transport of the container. - The container shown in the drawings is used in the following way:
Den ovre kapselhalvdel presses ned slik at kantenThe upper capsule half is pressed down so that the edge
8 bryter den membranformede skilleveggen og komponenten 7 8 breaks the membrane-shaped partition and component 7
trenger ned i den lavere kapselhalvdel. Beholderen rystes eller knas for å få blanding av komponentene i blandingen. Spissen 9 brytes av og beholdéren presses for å fordele innholdet gjennom fordelingskanalen 10. For et farmasoytisk preparat for oral tilforsel bringes beholderen til pasientens munn for å fordele innholdet. penetrates into the lower capsule half. The container is shaken or crushed to mix the components in the mixture. The tip 9 is broken off and the container is pressed to distribute the contents through the distribution channel 10. For a pharmaceutical preparation for oral administration, the container is brought to the patient's mouth to distribute the contents.
Kapselhalvdelene fremstilles fortrinnsvis av mykt plastmateriale. Forskjellige laminerte materialer kan anvendes for å få en tilstrekkelig ugjennomtrengelighet.. For å gjore det mulig med visuell inspeksjon av blandingen, kan kapselhalvdelene fremstilles av transparent materiale. Skille veggen er fremstilt av et materiale som er ugjennomtrengelig The capsule halves are preferably made of soft plastic material. Various laminated materials can be used to obtain sufficient impermeability. To enable visual inspection of the mixture, the capsule halves can be made of transparent material. The partition wall is made of a material that is impermeable
for væsker og som kan brytes,såsom plastbelagt aluminiumfolie. for liquids and which can be broken, such as plastic-coated aluminum foil.
Delene i beholderen festes fortrinnsvis sammen ved varmefor-segling langs flensene i kapselhalvdelene. The parts in the container are preferably attached together by heat sealing along the flanges in the capsule halves.
Oppfinnelsen gjor det også mulig med tilsatsav midler til den torre komponent i et farmasoytisk preparat hvor disse midler har en kjolevirkning når de oppløses i vann. , Mikroinnkapslede produkter kan anvendes som en opplosning er ikke nodvendig, men bare en suspensjon som er helt ustabil? . The invention also makes it possible to add agents to the dry component in a pharmaceutical preparation where these agents have a dressing effect when dissolved in water. , Microencapsulated products can be used as a solution is not necessary, but only a suspension that is completely unstable? .
" ■' 'i/ behøver fremstilles i væsken. Smaksforbedrende midler.kan' tilfores f.eks. i væskekomponenten i den farmasøytiske blanding. "■' 'i/ need to be prepared in the liquid. Flavor-improving agents can be added, for example, in the liquid component of the pharmaceutical mixture.
Innen det farmasøytiske området er ikke oppfinnelsen begrenset til anvendelsen av beholderen for antibiotiske blandinger. Som eksempler på andre farmasøytiske preparater som kan anvendes skal der nevnes forskjellige oppløsninger av aminosyrer og vitaminer hvor disse oppløsninger kan tilfores sammen under anvendelse av beholderen ifolge oppfinnelsen. Within the pharmaceutical field, the invention is not limited to the use of the container for antibiotic mixtures. As examples of other pharmaceutical preparations that can be used, mention must be made of different solutions of amino acids and vitamins where these solutions can be administered together using the container according to the invention.
Storrelsen på beholderen kan varies innenfor vide grenser som settes av de krav at beholderen stort sett må være manipulerbar for hånden. Passende kan beholderen inneholde minst 1 ml blanding. The size of the container can be varied within wide limits set by the requirements that the container must be largely manipulable by hand. Suitably, the container may contain at least 1 ml of mixture.
Claims (6)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7707709A SE7707709L (en) | 1977-07-04 | 1977-07-04 | ENDOS CONTAINER FOR DRUG PREPARATIONS |
| SE7713547A SE7713547L (en) | 1977-11-30 | 1977-11-30 | CONTAINER FOR TWO-COMPONENT MIXTURES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO782302L true NO782302L (en) | 1979-01-05 |
Family
ID=26656833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO782302A NO782302L (en) | 1977-07-04 | 1978-07-03 | CONTAINER FOR TWO-COMPONENT MIXTURES |
Country Status (11)
| Country | Link |
|---|---|
| JP (1) | JPS5418394A (en) |
| AU (1) | AU3709378A (en) |
| DE (1) | DE2828283A1 (en) |
| DK (1) | DK295078A (en) |
| FI (1) | FI782117A (en) |
| FR (1) | FR2396701A1 (en) |
| GB (1) | GB2002316A (en) |
| IT (1) | IT7850124A0 (en) |
| LU (1) | LU79912A1 (en) |
| NL (1) | NL7806902A (en) |
| NO (1) | NO782302L (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT8253546V0 (en) * | 1982-07-21 | 1982-07-21 | Ferrero Spa | CONTAINER FOR FOOD PRODUCTS PARTICULARLY SWEET PRODUCTS |
| US4978502A (en) * | 1987-01-05 | 1990-12-18 | Dole Associates, Inc. | Immunoassay or diagnostic device and method of manufacture |
| DE3873787T2 (en) * | 1987-02-17 | 1993-01-21 | Cmb Foodcan Plc | ANALYTICAL TEST STRIP. |
| GB8703578D0 (en) * | 1987-02-17 | 1987-03-25 | Metal Box Plc | Analytical test strip |
| GB2238767B (en) * | 1989-12-06 | 1993-10-20 | Femcare Ltd | Medical sponge system |
| FR2744991B1 (en) | 1996-02-15 | 1998-03-20 | Oreal | SINGLE-BODY MIXER, FOR SEPARATE PACKAGING AND MIXING OF AT LEAST TWO PRODUCTS |
| DE19627243A1 (en) * | 1996-07-08 | 1998-01-15 | Hassia Verpackung Ag | Packaging for two filling material components for oral administration of medication |
| GB9817578D0 (en) | 1998-08-12 | 1998-10-07 | Cambridge Consultants | Pack |
| GB9817576D0 (en) | 1998-08-12 | 1998-10-07 | Cambridge Consultants | Container and packaging method |
| GB9817575D0 (en) | 1998-08-12 | 1998-10-07 | Cambridge Consultants | Pack |
| DE10360366A1 (en) * | 2003-12-22 | 2005-07-21 | Agfaphoto Gmbh | Containers for photographic processing chemicals |
| EP3069707A1 (en) | 2011-10-06 | 2016-09-21 | Binutra Incorporated | A method and apparatus for manufacturing a capsule |
| US9456987B2 (en) | 2013-04-03 | 2016-10-04 | Binutra, Inc. | Capsule with internal diaphragm |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB191208931A (en) * | 1912-04-16 | 1913-04-16 | Albert Andrew Kelly | An Improved Method of Making Air-tight Packages. |
| FR1215472A (en) * | 1959-02-04 | 1960-04-19 | Double capsule for the distribution of two products to be mixed in well-defined proportions at the time of their use, in particular for the preparation of dental amalgams | |
| FR1271583A (en) * | 1962-03-24 | 1962-01-19 | ||
| CH596136A5 (en) * | 1973-07-31 | 1978-02-28 | Nippon Catalytic Chem Ind |
-
1978
- 1978-06-14 AU AU37093/78A patent/AU3709378A/en active Pending
- 1978-06-27 NL NL7806902A patent/NL7806902A/en not_active Application Discontinuation
- 1978-06-28 FR FR7819390A patent/FR2396701A1/en not_active Withdrawn
- 1978-06-28 DE DE19782828283 patent/DE2828283A1/en not_active Withdrawn
- 1978-06-29 DK DK295078A patent/DK295078A/en unknown
- 1978-06-30 GB GB7828397A patent/GB2002316A/en not_active Withdrawn
- 1978-06-30 FI FI782117A patent/FI782117A/en not_active Application Discontinuation
- 1978-06-30 IT IT7850124A patent/IT7850124A0/en unknown
- 1978-07-03 NO NO782302A patent/NO782302L/en unknown
- 1978-07-03 LU LU79912A patent/LU79912A1/en unknown
- 1978-07-04 JP JP8181778A patent/JPS5418394A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5418394A (en) | 1979-02-10 |
| AU3709378A (en) | 1979-12-20 |
| NL7806902A (en) | 1979-01-08 |
| GB2002316A (en) | 1979-02-21 |
| LU79912A1 (en) | 1979-04-09 |
| DE2828283A1 (en) | 1979-01-18 |
| FR2396701A1 (en) | 1979-02-02 |
| IT7850124A0 (en) | 1978-06-30 |
| DK295078A (en) | 1979-01-05 |
| FI782117A (en) | 1979-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4465488A (en) | Collapsible multi-chamber medical fluid container | |
| US5718681A (en) | Medication delivery straw | |
| NO782302L (en) | CONTAINER FOR TWO-COMPONENT MIXTURES | |
| KR920000436B1 (en) | Drug delivery system | |
| RU2471474C2 (en) | Agent dispenser and sublingual device | |
| US5196001A (en) | Devices and methods for preparing pharmaceutical solutions | |
| JPS63178969A (en) | Vessel device for separately storing and mixing two component | |
| DK0541715T3 (en) | Flexible multi-chamber drug container | |
| HUT45904A (en) | Instrument for dosing pharmaceutical products of suspension form | |
| CO4340640A1 (en) | STERILE, FLEXIBLE CONTAINER AND METHOD FOR MANUFACTURE AND USE | |
| Lockhart et al. | Packaging of pharmaceuticals and healthcare products | |
| US20050053648A1 (en) | Medication delivery device | |
| EP0539489B1 (en) | A device and method for dosing a liquid product | |
| GB2207652A (en) | Container assembly for storing two injection medicaments | |
| US20060037928A1 (en) | Container comprising a transparent cylindrical container wall | |
| AU1573988A (en) | Arrangement for and method of administering a pharmaceutical preparation | |
| EP0388361A3 (en) | Apparatus for filling blister packs | |
| US20200369454A1 (en) | Container and method for reconstitution of substances | |
| US20040006303A1 (en) | Oral medicine delivery apparatus | |
| GB2210014A (en) | A medicine and beverage package | |
| SE465317B (en) | MEDICINAL PACKAGING AND COMBINATION PACKAGING FOR MEDICINAL PRODUCTS AND APPLICATION OF MEDICINAL PACKAGING FOR PREPARING A COMBINATION PACKAGING | |
| US1572324A (en) | Medicinal and anesthetic package | |
| US20050070873A1 (en) | Constituent delivery system | |
| JPH1033637A (en) | Mixing and packaging device of liquid agent | |
| JPS5686117A (en) | Medicinal composition and injection vessel |